Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

26 mars 2026 09h15 HE | Source: Edesa Biotech, Inc.

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
26 mars 2026 09h15 HE | Source: Neion Bio, Inc.

Neion Bio Emerges from Stealth with Multi-Product Biosimilar Partnership Leveraging Its Cutting-Edge Genetic Engineering Platform

Neion Bio exits stealth with first biosimilar co-development and supply partnership, leveraging its genetic engineering platform to enable scalable, lower-
26 mars 2026 09h00 HE | Source: Interlink Electronics, Inc.

Interlink Electronics Reports Fourth Quarter 2025 Results

FREMONT, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK) (“Interlink” or the “Company”), a global leader in sensor technology and printed electronic solutions,...
26 mars 2026 08h30 HE | Source: RenovoRx, Inc.

RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment

TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for...
26 mars 2026 08h30 HE | Source: Achieve Life Sciences

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

SEATTLE and VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global...
26 mars 2026 08h00 HE | Source: Daxor Corporation

Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026

OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the...
26 mars 2026 07h30 HE | Source: Dynacor Group Inc.

Dynacor: Strong Fourth Quarter Caps Record Financial Performance and Expanded Growth Pipeline in 2025

Dynacor Group Inc. (TSX: DNG) today announced its financial and operational results for the year and quarter ended December 31, 2025.
26 mars 2026 07h30 HE | Source: Medicus Pharma Ltd

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

PHILADELPHIA, March 26, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...
26 mars 2026 07h30 HE | Source: Wave Life Sciences USA, Inc.

Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p<0.05) and total fat (-5%),...
26 mars 2026 07h00 HE | Source: Verde AgriTech Ltd

Verde AgriTech Announces Q4 & FY 2025 Earnings Results

All figures are in Canadian dollars unless otherwise stated. BELO HORIZONTE, Brazil and SINGAPORE, March 26, 2026 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: NPK | OTCQX: VNPKF) ("Verde” or the...

Page précédente

Page suivante